B2B pharmaceutical company and medical cannabis cultivator ECS Botanics (ASX: ECS) has secured an offtake agreement to supply medical cannabis dried flowers to Perth-based medical cannabis company MediCann Health over the next five years.
Read More
Australian digital health company 1st Group’s (ASX: 1ST) telehealth subsidiary, Visionflex, has clinched a significant deal with the Western Australia Primary Health Alliance (WAPHA). This marks Visionflex’s second purchase order from WAPHA for an additional 75 Visionflex Clinical Telehealth Carts, valued at over $1.1 million. The initial order, placed in August 2023, consisted of the
Read More
Advanced marine propulsion and stabilisation system developer VEEM (ASX: VEE) has signed an exclusive agreement with nautical engineering company Sharrow Engineering.
Read More
Radiopharmaceutical company Cyclopharm (ASX: CYC) is set to begin commercial sales of its lung imaging device Technegas in the US, following the Food and Drug Administration’s (FDA) stamp of approval on September 30.
Read More
Following a successful strategy of acquiring wind-up businesses, tech company Rewardle (ASX: RXH) is set to offer micro investment services having acquired fintech Upstreet for pennies-on-the-dollar, just as the start-up was shutting down. Founded in 2019 within the Antler venture capital accelerator program, Upstreet originally set out to reward shoppers with fractional shares in Australian
Read More
According to the US Food and Drug Administration (FDA), Precision Medicine, or “personalised medicine”, is a new way of tailoring disease care by considering people’s unique genes, environments, and lifestyles. The goal is to give the right treatments at the right time.
Read More
In a significant development that continues to revolutionise healthcare services in Hong Kong, Mach7 Technologies (ASX: M7T) has announced a five-year extension of its partnership with the Hospital Authority of Hong Kong (HAHK).
Read More
In 2023, pancreatic cancer transitioned from being a rare form to a common cancer in Australia—a troublesome statistic, seeing as it has very low survival rates of about 12%. The symptoms of pancreatic cancer are in advanced stages, making it difficult to treat.
Read More
We have all but entered the silly season as people gear up for Black Friday, Cyber Monday, Christmas, Boxing Day and New Year’s Eve sales. They’ve got the seasonal bonuses and holidays to make the most of it. What’s more, these sales manage to perk up economies, with last year’s Black Friday sale generating record
Read More
Traditional cannabis in the form of oil has had an absorption problem, making it less effective. But what if you blended it with starch, which boasts greater absorption without messing with the compound? Cannabis-focused drug development company Bod Science (ASX: BOD) undertook a study on the same, delivering some positive results. So positive, in fact,
Read More
